a public good project by the
Synthesis
Company
of California

© 2026

Meng‐Han Bo | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Meng‐Han Bo

Shanghai University of Traditional Chinese Medicine(CN)Yueyang Hospital(CN)

Research Areas

Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, Liver physiology and pathology

Most-Cited Works

→ Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma(2022)42 cited